Headache & Migraine
Conference Coverage
Consistent effects for galcanezumab in cluster headache
Most patients whose PGI-I score improved in one cluster bout also improved in a subsequent bout.
Conference Coverage
Marijuana for migraine? Some tentative evidence
A small study hints at efficacy, especially as an abortive treatment.
News
Headache may predict clinical evolution of COVID-19
Headache onset could occur during the presymptomatic or symptomatic phase of COVID-19 and could resemble tension-type or migraine headache.
Conference Coverage
Adding CGRP to Botox is safe and effective for migraine prevention
Conference Coverage
Commonalities challenge the threshold of high-frequency episodic and low-frequency chronic migraine
Study reports commonalities between high-frequency episodic and low-frequency chronic migraine, raising questions about current diagnostic...
Conference Coverage
NSAID/triptan combination improves treatment-resistant migraine
A combination of rizatriptan and meloxicam formulated to improve oral absorption led to better outcomes than rizatriptan alone.
Conference Coverage
CGRPs in real world: Similar efficacy, more AEs
A real-world study of monoclonal antibody agents reported comparable efficacy but more adverse events than clinical trials.
Conference Coverage
Intranasal DHE shows promise in migraine
New formulation of DHE joins other efforts to improve delivery of existing drugs.
Conference Coverage
Persistent posttraumatic headache risk factors confirmed
An analysis of 300 patients with posttraumatic headache reveals some long-suspected risk factors of persistent headache, but also a high...
Conference Coverage
Few patients with migraine clear barriers to optimal care
Less than 8% of patients with episodic migraine and less than 2% of patients with chronic migraine were able to overcome four key treatment...